Marker Therapeutics, Inc. (MRKR)
2.04
-0.15
(-6.85%)
USD |
NASDAQ |
Jan 22, 16:00
2.07
+0.03
(+1.47%)
After-Hours: 07:58
Marker Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 126.08M |
| ADMA Biologics, Inc. | -14.37M |
| Kiniksa Pharmaceuticals International Plc | -62.76M |
| Neurocrine Biosciences, Inc. | -196.70M |
| AIM ImmunoTech, Inc. | 0.296M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.736M |
| Cash from Financing (Quarterly) | 9.864M |
| Free Cash Flow | -14.82M |
| Free Cash Flow Per Share (Quarterly) | -0.1633 |
| Free Cash Flow to Equity (Quarterly) | -2.736M |
| Free Cash Flow to Firm (Quarterly) | -2.736M |
| Free Cash Flow Yield | -57.06% |